Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma

Cancer Biology and Therapy

Volumn 10, Issue 5, 2010, Pages 425-429

  Du, Kevin L ^a   Both, Stefan ^a   Friedberg, Joseph S ^a   Rengan, Ramesh ^a   Hahn, Stephen M ^a   Cengel, Keith A ^a  

^a NONE

Author keywords

Extrapleural pneumonectomy; Hemithoracic radiation therapy; IMRT; Mesothelioma; Photodynamic therapy

Indexed keywords

CISPLATIN; PEMETREXED; PHOTOFRIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COUGHING; CYTOREDUCTIVE SURGERY; DECREASED APPETITE; DESQUAMATION; DYSPNEA; ERYTHEMA; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; LUNG TOXICITY; MALE; MALIGNANT PLEURA MESOTHELIOMA; PHOTODYNAMIC THERAPY; PLEURA MESOTHELIOMA; QUALITY OF LIFE; RADIATION DOSE; RADIATION PNEUMONIA; RESPIRATORY FAILURE; TARGET ORGAN; THERAPY EFFECT; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME; WEIGHT REDUCTION;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PHOTOCHEMOTHERAPY; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIATION PNEUMONITIS; RADIOTHERAPY, INTENSITY-MODULATED; RESPIRATORY INSUFFICIENCY; THORACIC CAVITY; TREATMENT OUTCOME;

EID: 77957130116     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.5.12616     Document Type: Article

References (18)

1. Forster KM, Smythe WR, Starkschall G, Liao Z, Takanaka T, Kelly JF, et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 2003; 55:606-16. (Pubitemid 36170001)
2. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003; 55:768-75.
3. Miles EF, Larrier NA, Kelsey CR, Hubbs JL, Ma J, Yoo S, Marks LB. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys 2008; 71:1143-50.
4. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007; 84:1685-92; discussion 92-3.
5. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2007; 69:350-7. (Pubitemid 47381562)
6. Allen AM, Czerminska M, Janne PA, Sugarbaker DJ, Bueno R, Harris JR, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006; 65:640-5.
7. Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg 2003; 75:952-9.
8. Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol 2004; 22:2192-201. (Pubitemid 41095155)
9. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001; 122:788-95.
10. Jaklitsch MT, Grondin SC, Sugarbaker DJ. Treatment of malignant mesothelioma. World J Surg 2001; 25:210-7.
11. Baldini EH, Recht A, Strauss GM, DeCamp MM Jr, Swanson SJ, Liptay MJ, Mentzer SJ, Sugarbaker DJ. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997; 63:334-8.
12. Yajnik S, Rosenzweig KE, Mychalczak B, Krug L, Flores R, Hong L, Rusch VW. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003; 56:1319-26.
13. Hill-Kayser CE, Avery S, Mesina CF, James P, Friedberg JS, Cengel K, et al. Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques. J Thorac Oncol 2009.
14. Komaki R, Liao Z, Liu H, Tucker S, Rice D. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006; 65:640-5). Int J Radiat Oncol Biol Phys 2006; 66:1595-6; author reply 6.
15. Kong FM, Ten Haken R, Eisbruch A, Lawrence TS. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol 2005; 32:42-54.
16. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006; 66:1399-407.
17. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005; 63:672-82. (Pubitemid 41400051)
18. Della Volpe A, Ferreri AJ, Annaloro C, Mangili P, Rosso A, Calandrino R, et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002; 52:483-8. (Pubitemid 34170853)